Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model

Henry T. Lynch, Jane F. Lynch, Thomas A. Attard

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Increased knowledge of genetics and molecular pathophysiologic pathways holds the promise for the development and timing of screening measures, such as colonoscopy, which may facilitate detection of presymptomatic cancer and potentially a reduction of mortality. Insight into the molecular genetic mechanisms of hereditary cancer syndromes may improve targeted cancer control measures and pharmacologic therapy. Thus, it may one day become possible to select therapy based on genomic or proteomic profiles for targeted molecular-based pharmacologic therapy. Physicians must attain a better grasp of hereditary cancer syndromes and, when more expertise is needed, make appropriate referrals to experienced medical geneticists or a centre with expertise in hereditary cancer. Lives can be saved through cancer prevention using genetic knowledge.

Original languageEnglish
Pages (from-to)273-280
Number of pages8
JournalCanadian Medical Association Journal
Volume181
Issue number5
DOIs
StatePublished - Sep 1 2009

Fingerprint

Hereditary Neoplastic Syndromes
Hereditary Nonpolyposis Colorectal Neoplasms
Colorectal Neoplasms
Molecular Biology
Neoplasms
Hand Strength
Colonoscopy
Proteomics
Therapeutics
Referral and Consultation
Physicians
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Diagnosis and management of hereditary colorectal cancer syndromes : Lynch syndrome as a model. / Lynch, Henry T.; Lynch, Jane F.; Attard, Thomas A.

In: Canadian Medical Association Journal, Vol. 181, No. 5, 01.09.2009, p. 273-280.

Research output: Contribution to journalReview article

@article{32bcbc3653844905888a808481641392,
title = "Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model",
abstract = "Increased knowledge of genetics and molecular pathophysiologic pathways holds the promise for the development and timing of screening measures, such as colonoscopy, which may facilitate detection of presymptomatic cancer and potentially a reduction of mortality. Insight into the molecular genetic mechanisms of hereditary cancer syndromes may improve targeted cancer control measures and pharmacologic therapy. Thus, it may one day become possible to select therapy based on genomic or proteomic profiles for targeted molecular-based pharmacologic therapy. Physicians must attain a better grasp of hereditary cancer syndromes and, when more expertise is needed, make appropriate referrals to experienced medical geneticists or a centre with expertise in hereditary cancer. Lives can be saved through cancer prevention using genetic knowledge.",
author = "Lynch, {Henry T.} and Lynch, {Jane F.} and Attard, {Thomas A.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1503/cmaj.071574",
language = "English",
volume = "181",
pages = "273--280",
journal = "CMAJ",
issn = "0008-4409",
publisher = "Canadian Medical Association",
number = "5",

}

TY - JOUR

T1 - Diagnosis and management of hereditary colorectal cancer syndromes

T2 - Lynch syndrome as a model

AU - Lynch, Henry T.

AU - Lynch, Jane F.

AU - Attard, Thomas A.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Increased knowledge of genetics and molecular pathophysiologic pathways holds the promise for the development and timing of screening measures, such as colonoscopy, which may facilitate detection of presymptomatic cancer and potentially a reduction of mortality. Insight into the molecular genetic mechanisms of hereditary cancer syndromes may improve targeted cancer control measures and pharmacologic therapy. Thus, it may one day become possible to select therapy based on genomic or proteomic profiles for targeted molecular-based pharmacologic therapy. Physicians must attain a better grasp of hereditary cancer syndromes and, when more expertise is needed, make appropriate referrals to experienced medical geneticists or a centre with expertise in hereditary cancer. Lives can be saved through cancer prevention using genetic knowledge.

AB - Increased knowledge of genetics and molecular pathophysiologic pathways holds the promise for the development and timing of screening measures, such as colonoscopy, which may facilitate detection of presymptomatic cancer and potentially a reduction of mortality. Insight into the molecular genetic mechanisms of hereditary cancer syndromes may improve targeted cancer control measures and pharmacologic therapy. Thus, it may one day become possible to select therapy based on genomic or proteomic profiles for targeted molecular-based pharmacologic therapy. Physicians must attain a better grasp of hereditary cancer syndromes and, when more expertise is needed, make appropriate referrals to experienced medical geneticists or a centre with expertise in hereditary cancer. Lives can be saved through cancer prevention using genetic knowledge.

UR - http://www.scopus.com/inward/record.url?scp=70349148223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349148223&partnerID=8YFLogxK

U2 - 10.1503/cmaj.071574

DO - 10.1503/cmaj.071574

M3 - Review article

C2 - 19654196

AN - SCOPUS:70349148223

VL - 181

SP - 273

EP - 280

JO - CMAJ

JF - CMAJ

SN - 0008-4409

IS - 5

ER -